Financhill
Back

Coca-Cola Femsa SAB de CV Vs. Novo Nordisk AS Industry Stock Comparison

Buy
62

COCSF
Coca-Cola Femsa SAB de CV

Last Price:
$8.0600
Seasonality Move:
-0.84%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Buy
62
Coca-Cola Femsa SAB de CV (COCSF) is a Buy

Is Coca-Cola Femsa SAB de CV a Buy, Sell or Hold?

  • The current Coca-Cola Femsa SAB de CV [COCSF] share price is $8.0620. The Score for COCSF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • COCSF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

COCSF Stock Price Chart

What is Coca-Cola Femsa SAB de CV's stock price today?

  • The Coca-Cola Femsa SAB de CV share price today is $8.0620
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and COCSF is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

COCSF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 49.43 Sell
Chaikin Money Flow: 6132 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.7815 - 8.2615) Buy
Bollinger Bands (100): (8.0925 - 9.0325) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

COCSF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.05 Buy
20-day SMA: 8.01 Buy
50-day SMA: 8.26 Sell
200-day SMA: 8.89 Sell
8-day EMA: 8.09 Sell
20-day EMA: 8.07 Sell
50-day EMA: 8.24 Sell
200-day EMA: 8.65 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Coca-Cola Femsa SAB de CV Earnings Growth & COCSF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Coca-Cola Femsa SAB de CV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):